# EXALGO
> **NDA021217** · New Drug Application · Sponsor: SPECGX LLC · Approved 2010-03-01
## Drug
- **FDA Application Number:** NDA021217
- **Application type:** New Drug Application
- **Brand name:** EXALGO
- **Generic name:** Hydromorphone Hydrochloride
- **Active ingredients:** HYDROMORPHONE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SPECGX LLC
- **First approval:** 2010-03-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021217)
---
*MORVS · CC0 1.0*